4
Changes in Ownership
Hepion Pharmaceuticals, Inc. Filed Acc 0001104659-23-101784
CEO and Director bought 1,600 shares at $5.60 ($8,960)
From the SEC's structured data for this filing
Trades in this filing
Foster Robert T · CEO and Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-09-18 | Purchase : show line 1 in the form | +1,600 | $5.60 | $8,960 | 50,470 | D |
| Open-market purchases · 1,600 sh · avg $5.60 · $8,960 | ||||||
Loading xslF345X05/tm2326377-1_4seq1.xml…